PetVivo Animal Health Surgery Solutions

Enhance joint support post-surgery using Spryng and PrecisePRP, tailored for today’s veterinary surgeons.

Revolutionize Recovery with Regenerative Therapies

Discover how Spryng and PrecisePRP elevate post-operative outcomes for mobile and clinic-based veterinary surgeons.

Spryng® with OsteoCushion® Technology

Spryng is a naturally derived intra-articular injectable medical device made from collagen and elastin. It works to enhance joint cushioning and synovial fluid viscosity, and promote constructive tissue remodeling - making it an ideal solution for supporting joint recovery following orthopedic surgeries such as cruciate ligament or luxating patella procedures, or providing prophylactic support for the opposite limb during recovery.

PrecisePRP is a shelf-stable, leucoreduced platelet-rich plasma that eliminates the need for centrifugation while delivering consistent, reliable dosing. It integrates easily into your surgical protocols - supporting tissue regeneration, reducing inflammation, and accelerating recovery in tendon, ligament, and joint procedures.  

(Now available for canine patients with equine coming Fall 2025) 

PrecisePRP™

Video Resources

Surgical Applications for PrecisePRP

See how veterinary surgeon Dr. Kirsty Husby recommends integrating PRP into your surgical protocols to help reduce inflammation, accelerate tissue healing, and support better patient outcomes - and how PrecisePRP can make it easier than ever.

Surgical Applications for Spryng

Veterinary surgeon Dr. Kirsty Husby explains how Spryng, a collagen and elastin-based injectable device, supports joint recovery in dogs and horses after orthopedic surgery. Drug-free and suitable for competitive animals, Spryng helps improve joint biomechanics, may reduce reliance on chronic pain medications, and supports long-term mobility making it ideal for OA, cruciate repair, and post-trauma care.

PrecisePRP Technical Resources

PrecisePRP Canine available now. PrecisePRP Equine coming Fall 2025.

PrecisePRP Frequently Asked Questions

PrecisePRP Canine Prescribing Information

PrecisePRP Characterization

PrecisePRP Efficacy and Safety Overview

Spryng Technical Resources

Instructions For Use

Administration Guidelines

Veterinarian FAQs

Frequently Asked Questions

*

Frequently Asked Questions *

  • Spryng is intended to aid in maintaining the mechanical homeostasis of tissues within and adjacent to the synovial lining of the joint in dogs, cats, and horses.

    Spryng is indicated to aid in the management of noninfectious sources of joint pain including, but not limited to, abnormal joint biomechanics, joint instability, osteoarthritis, and congenital orthopedic conditions.

  • Spryng bioscaffolds, composed of naturally derived collagen, elastin, and a glycosaminoglycan, mimic the composition and mechanical properties of extracellular matrix. Spryng may promote a constructive restoration of diseased synovial tissue to improve the biomechanics and mechanical homeostasis of the joint.

    An unhealthy synovial lining can contribute to rapid progression of joint disease such as OA. Arthritic joints undergo fibrotic remodeling, affecting all layers, not just the synovium. This impacts range of motion, blood supply, and movement of inflammatory cells, resulting in altered homeostasis and mechanical joint dysfunction. It has been hypothesized that modifying fibrosis could encourage functional tissue restoration. 

  • PrecisePRP™ is an allogeneic (donor-derived), freeze-dried, pooled platelet-rich plasma product intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration. PrecisePRP™ is for veterinary use only and is currently available in species-specific format for dogs and horses.

  • You do not need a centrifuge or anticoagulant. To use PrecisePRP™, simply reconstitute with 8 mL of sterile water and inject. See prescribing information for complete rehydration instructions.